外科學總論課件:cancer_第1頁
外科學總論課件:cancer_第2頁
外科學總論課件:cancer_第3頁
外科學總論課件:cancer_第4頁
外科學總論課件:cancer_第5頁
已閱讀5頁,還剩66頁未讀, 繼續(xù)免費閱讀

下載本文檔

版權說明:本文檔由用戶提供并上傳,收益歸屬內(nèi)容提供方,若內(nèi)容存在侵權,請進行舉報或認領

文檔簡介

2023/8/24CANCER

—Principles&PracticeofOncology2023/8/24Neoplasms(Tumor,Mass)

Analteredcellpopulationcharacterizedbyanexcessive,nonusefulproliferationofcellsthathavebecomeunresponsivetonormalcontrolmechanismsandtotheorganizinginfluencesofadjacenttissues.2023/8/24ClassificationofNeoplasmsBenigntumorMalignanttumor(Cancer)CarcinomaSarcomaBorderingtumor2023/8/24EssentialsofModernOncologicScienceEssentialsofMoledularBiology:GenomicsandCancerEssentialsofSignalTransductionEssentialsofImmunology2023/8/24PrinciplesofOncologyMolecularBiologyofCancer:OncogenesIdentificationofOncogenesandTumorSuppressorGenesFunctionofOncogenesandTumorSuppressorGenes2023/8/24TumorRelatedGenesOncogene,proto-oncogene

ras,myc,erb2,src,c-fos,c-junetc.Tumorsuppressgene

RB,p53,APC,WT1etc.

DNAdamageandrepairrelatedgene

hMSH2,hMLH1,PMS1,PMS22023/8/24FunctionofOncogenesandTumorSuppressorGenes

SignalTransduction(ras)ExtracellularGrowthFactors(Sis)ReceptorTyrosineKinases(RET)NuclearProteinsandTranscriptionfactors(jun,BRCA1,2,myc,myb)CellCycle/DNADamageResponse(p53,RB,hMSH,MDM-2)2023/8/24MolecularMarkersinCancerDiagnosisChromosomalrearrangementsDNArearrangementsSmallMutation:K-ras,p53,APCTissue-specifictranscriptsViralgenomes2023/8/242023/8/24高通量分析技術——TissueArray2023/8/242023/8/24檢測大腸癌及轉移灶的不同組織基因表達研究 正常組織、結腸癌及癌旁組織 肝轉移組織及淋巴結轉移灶

FAP的不同部位的組織塊高通量分析技術——基因芯片(GeneChip)基因芯片技術日益成熟,在生命科學領域的應用更為廣泛GenePMMMOligo2023/8/24Telomerase,CellAgingandCancer

TimeTelomereLengthCriticalTelomereLengthNormalCellsStem&TumorCells2023/8/24MoledularBiologyofCancerCytogeneticsTheCellCycleApoptosisAngiogenesisInvasionandMetastasis2023/8/242023/8/242023/8/242023/8/24組織細胞數(shù)量=細胞增殖-細胞死亡TissueCellNo.=CellProliferation-CellDeath

癌基因和抗癌基因OncogenesandTumorSuppressorGenes凋亡和抗凋亡基因ApoptosisGeneandAnti-apoptosisGene2023/8/24正常粘膜I

癌轉移APCK-rasDCCP53nm23?其它甲基化5q突變.缺失12p突變18q突變?缺失17p突變.缺失IIIIIIVAdenomaMCChMSH2hMLH1hPMS1hPMS2ACFCOX-2SNC6,SNC73SNC19,maspin,osteo2023/8/242023/8/24EtiologyofCancerViruses(DNAandRNAViruses)ChemicalFactorsPhysicalFactorsHormonalFactorsCancerGenetics(Hereditaryfactors)2023/8/24腫瘤發(fā)生機制環(huán)境、飲食生物性因素遺傳易感性酶的多態(tài)性基因不穩(wěn)定MSIIntereactionDNA損傷修復修復DNA突變癌變?nèi)旧w不穩(wěn)定作用后出現(xiàn)的分子產(chǎn)物(基因與蛋白)

2023/8/24CancerGeneticsCancerasaGeneticDiseaseMechanismsofCancerPredispositionClinicalCharacteristicsofCancerFamiliesMultisystemGeneticSyndromesWithaHighRiskofCancerNonsyndromicHereditaryCancer2023/8/24EpidemiologyofCancerHumanCarcinogenesis:TheNatureoftheEvidenceCancerEpidemiologybySiteAnOverviewofCancerCauses2023/8/24CancerPrevention:PreventingTobacco-RelatedCancersDietandChemopreventiveAgents:Fat:BreastCancer,ColonCancer,ProstateCancerandotherCancerDietaryFibersRetinoids,Carotenoids,andMicronutrientsNaturallyOccurringDietaryAnticarcinogensDietaryCarcinogensAspirinandOtherNonsteroidalAntiinflammatoryDrugsandtheRiskofCancerDevelopmentPhysicalActivityandBodyWeightRoleofSurgeryinCancerPrevention2023/8/24CancerScreeningWhatisCancerScreening?EvaluationofAscreeningTestBreastCancerScreeningCervicalCancerScreeningSkinCancerScreeningProstateCancerScreeningColorectalCancerScreeningLungCancerScreening2023/8/24PathologyofNeoplasmsCarcinogenesisandTumorigenesisTumorcelldifferentiationGrowthpatternGrowthrate(speed)MetastasisDirectExtensionLymphaticSpreadVascularSpreadSpreadthroughSerousCavities2023/8/24CancerDiagnosis:MolecularPathologyImmunohistochemistryDNAContentDiagnosticMolecularGeneticsTechniquesintheMolecularGeneticDiagnosisofCancerMolecularMarkersinCancerDiagnosisSmallMutationsFutureExpectations2023/8/24ClinicalManifestationsCancer’ssevenwarningsignalsChangeinbowelorbladderhabitsAsorethatdoesnothealUnusualbleedingordischargeThickeningorlumpinbreastorelsewhereIndigestionordifficultyinswallowingObviouschangeinwartormoleNaggingcoughorhoarseness2023/8/24LocalmanifestationsofcancerMassPainUlcerBleedingObstructionMetastaticManifestations2023/8/242023/8/242023/8/242023/8/24SystemicManifestationofcancerNon-specific:AnemiaLowfeverWeightlossInertiaAnorexia-cachexiaandothers2023/8/242023/8/24Diagnosisofcancershouldproceedinonorderlyfashion:Carefulhistory(Detailsofriskfactorsincludingfamilyhistoryandcurrentmedicationshouldbenotedinthepatientsrecords)ThoroughphysicalexaminationLaboratoryexaminationImagingexaminationCancerDiagnosis2023/8/24ClinicalBreast

ExaminationInspectionAsymmetrySkinlesionsSkinchangesNippleandareolaabnormalitiesPalpationtechniqueExaminationoftheNippleExaminationofregionallymphnodes(supraclavicular,infraclavicular,axillary)2023/8/24CancerDiagnosis:Imaging—UltrasonographyUltrasonographyisparticularlysuitableforthefollowingpatientgroups:Liver,gallbladder,spleenandpancreaseRetro-peritonealKidneyandadrenalglandBreastandthyroidUltrasoundobservationsBoundariesandshapeInternalechoesPosteriorshadowing2023/8/24CancerDiagnosis:Imaging—ComputedTomographyLiverandgallbladderPancreasandspleenKidneyandAdrenalGlandSmallBowelandColonEsophagusandStomachLungsandMediastinumMusculoskeletalSystemCentralNervousSystem2023/8/24CancerDiagnosis:Imaging—MagneticResonanceImagingBrain,SpineHeadandNeckBreastLiverAdrenalGlands,KidneyUterus,OvaryProstate,BladderMusculoskeletalSystem2023/8/24CancerDiagnosis:

OtherImagingsFunctionalandMetabolicImaging—PositronEmissionTomography(PET)InterventionalRadiologyRadionuclideImaging2023/8/242023/8/24CancerDiagnosis:EndoscopyUpperGastrointestinalEndoscopyEndoscopicUltrasonographySignoidoscopy,ColonoscopyLaparoscopyEndoscopicRetrogradeCholangiopancreatographySmallIntestinalEndoscopy:EnteroscopyPercutaneoisEndoscopicGastrostomyBronchoscopyMediastinoscopyThoracoscopy2023/8/24SpecializedTechniquesinCancerManagemntLaparoscopyVascularAccessandSpecializedTechniquesofDrugDeliveryIsolationPerfusionIntensity-ModulatedRadiationTherapy2023/8/24FineNeedleAspirationIndicationforFNAWhenphysicalexaminationormammographyofthebreastshowsasuspiciousabnormality,eitheradefinitemassorathickeningnotwithinthenormalrange,FNAisindicated.TodistinguishbetweenacystandacarcinomaFNAbiopsyorFNAcytologyUltrasound-guidedFNA2023/8/24BiopsyIndicationsforbiopsyaregenerallyderivedfromtheresultsofphysicalexaminationormammography.Twotechniquesareusedforobtainingtissuesuitableforhistologicalexamination,coreneedlebiopsy,andopenbiopsy.2023/8/24Core-cuttingneedlebiopsyStereotacticallyguidedneedlebiopsyNon-palpablelesionsOpenbiopsyIncisionalbiopsyExcisionalbiopsy(excision,marking,inking,review)Openbiopsyofnon-palpablelesionsHooked-wirelocalizationSpotlocalizationSkinbiopsy(Paget’sdisease,inflammatorycarcinoma)Biopsyofregionaladenopathy2023/8/24StagingCurrently,StagingofcancerisdeterminedbytheTNMsystemofclassification.T tumorN regionallymphnodesM distantmetastases(Primary,Local,RegionalandDistant)2023/8/24PrinciplesofCancerManagement:Goalsoftherapy–CureorPalliationThegoalsoftherapyvarywiththeextentofthecancer.Ifthecancerislocalizedwithoutevidenceofspread,thegoalistoeradicatethecancerandcurethepatient.Whenthecancerisspreadbeyondlocalcure,thegoalistocontrolthepatient’ssymptomsandtomaintainmaximumactivityforthelongestpossibleperiodoftime.2023/8/24PrinciplesofCancerManagement:SurgicalOncologyHistoricalPerspectiveAnesthesiaforOncologicSurgeryDeterminationofOperativeRiskRolesforSurgeryTheSurgicalOncologist2023/8/24SurgicalTherapyCancersurgeryhasbeenbasedupontheconceptthatcancerbeginsasalocaldiseaseandspreadsinanorderlyfashionfromtheprimarysitetoadjacenttissuesbydirectextensiontotheregionallymphnodesbylymphaticsandthroughthebloodvessels.Thesurgicalprocedurewasdesignedtoremovetheprimaryneoplasmsandtheusualcontiguousroutesofspreadwithaimofremovingeverycancercellfromthebody.2023/8/24SurgicalTherapyOnlyaboutone-thirdofcancerpatientsarecuredbysurgeryalone,sincesurgicaltherapy,withfewexceptions,iscurativeonlyinthosepatientsinwhomthediseaseislocalizedtotheprimarysiteandregionalnodes.Advancesinsurgicaltechniques,anesthesia,andsupportivecare(bloodtransfusion,antibiotics,etc)havepermittedthedevelopmentofmoreradicalandextensiveoperativeprocedures.2023/8/24SurgicalTherapyItisessentialtorealizethatthebest,andoftentheonly,opportunityforcureisatthetimeofthefirstoperation,sotheoperativeprocedureshouldbeplannedcarefully.Preventionofcancercellimplantationduringsurgery—localrecurrence.Preventionofvasculardisseminationatsurgery—blood-bornemetastases.“No-touch”technique,earlyligationofthevascularpedicle,etc.2023/8/24SurgicalTherapy:TypesofCancerOperationsLocalresection(atleastincludingsomenormaltissuessurrounding)RadicallocalresectionRadicalresectionwithenblocexcisionoflymphaticsExtensivesurgicalproceduresSurgeryofrecurrentcancerResectionofmetastasesPalliativesurgery2023/8/242023/8/24PrinciplesofCancerManagement:RadiationTherapyPhysicalConsiderationBiologicConsiderationsTumorradiobiologyClinicalConsiderations2023/8/24RadiotherapyObjectivesofRadiotherapyToday,it’srecognizedthatradiologistsmustoptimizetechniquesanddosesofradiotherapyinordertominimizetheriskoflocalrecurrence,achieveexcellentcosmeticresults,andavoidbothshort-andlong-termcomplications.2023/8/24TreatmentPlanningObtainCTScans

DefineTargetArea

EstablishIrradiationField

Construct3DImage

CreateBlocks

ConfirmDoseDistribution2023/8/24ThetechniqueofradiotherapyPatientmarkingsScheduleDoseBoostdoseExternal-beamradiotherapy(X-raysorelectrons)Interstitialimplantation2023/8/24ChemotherapyHistoryChemotherapyasPartoftheInitialTreatmentofCancerClinicalEndpointsinEvaluatingResponsetoChemotherapyPrinciplesGoverningtheUseofCombinationChemotherapyResponsetoChemotherapyIsAffectedbytheBiologyofTumorGrowthThecellCycle,DrugResistance,andtheP53TumorSuppressorGenePathwayTheconceptofDoseIntensityInVitroDrug-ResponseAssays2023/8/24TypesofChemotherapy

TheroleofchemotherapyAdjuvantchemotherapyNeo-adjuvantchemotherapyPalliativechemotherapyHigh-dosechemotherapy2023/8/24AdjuvantchemotherapyRationalforadjuvanttherapySubclinicalmetastases,therapydirectedattheprimarytumorisnothelpful,Systemictherapyaftersurgery,atatimewhenpatientsareclinicallyfreeofdiseasebutareathighriskofhavingresidualmicrometastases.Twotypesofsystemicapproachesareeffective,chemotherapy(cytotoxicagents)andhormonetherapy.2023/8/24AdjuvantchemotherapyTimingofAdjuvantchemotherapyChoiceofchemotherapySingle-agentchemotherapyCombinationchemotherapyNewcytotoxicagentsDoseDurationoftherapy2023/8/24ToxicityofadjuvantchemotherapyCommon:Myelosuppression AlopeciaNausea PrematureovarianfailureVomiting WeightgainLessCommon:SystemicinfectionsThrombosisNeurologicalproblems2023/8/24PalliativechemotherapyBenefits:Metastaticbreastcancerisverytreatableandisoneofthesolidtumormostresponsivetocytoto

溫馨提示

  • 1. 本站所有資源如無特殊說明,都需要本地電腦安裝OFFICE2007和PDF閱讀器。圖紙軟件為CAD,CAXA,PROE,UG,SolidWorks等.壓縮文件請下載最新的WinRAR軟件解壓。
  • 2. 本站的文檔不包含任何第三方提供的附件圖紙等,如果需要附件,請聯(lián)系上傳者。文件的所有權益歸上傳用戶所有。
  • 3. 本站RAR壓縮包中若帶圖紙,網(wǎng)頁內(nèi)容里面會有圖紙預覽,若沒有圖紙預覽就沒有圖紙。
  • 4. 未經(jīng)權益所有人同意不得將文件中的內(nèi)容挪作商業(yè)或盈利用途。
  • 5. 人人文庫網(wǎng)僅提供信息存儲空間,僅對用戶上傳內(nèi)容的表現(xiàn)方式做保護處理,對用戶上傳分享的文檔內(nèi)容本身不做任何修改或編輯,并不能對任何下載內(nèi)容負責。
  • 6. 下載文件中如有侵權或不適當內(nèi)容,請與我們聯(lián)系,我們立即糾正。
  • 7. 本站不保證下載資源的準確性、安全性和完整性, 同時也不承擔用戶因使用這些下載資源對自己和他人造成任何形式的傷害或損失。

評論

0/150

提交評論